Centre Hospitalier Universitaire de Besancon: Neoplasms trials
The registry lists 11 Neoplasms studies with Centre Hospitalier Universitaire de Besancon as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 2No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Quality of Life Assessment for Early Identification of Supportive Care Needs in Oncology PatientsNot yet recruitingNCT06337487Not applicable
- Preferences of Patients Treated With Oral Cancer Drugs and Informal Caregivers for Pharmaceutical Consultation in HospitalCompletedNCT05970471
- Molecular Markers in Cancers and Precancers (MOCA)WithdrawnNCT05257707Not applicable
- Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ)CompletedNCT03806712
- Combination Chemotherapy in Patients With Newly Diagnosed BPDCNActive, not recruitingNCT03599960Phase 2
- Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia.CompletedNCT02862288Phase 1/2
- Descriptive Study of the Efficacy of Treatments for Blastic Dendritic Cell Neoplasm (BPDCN)CompletedNCT02859623
- Study of T Specific Immune Response Against Delta-CD20 Peptide in Hematological Malignancies BTerminatedNCT02844491
- Decision to Limit or Withdraw Specific Therapies for Advanced Cancer and Hematological Malignancies.CompletedNCT02841124Not applicable
- Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1CompletedNCT02840058Not applicable
- Study of Genetic and Cellular Immunological Parameters Predictive of Disease-free Survival in Patients With Metastatic CancerCompletedNCT02838381Not applicable